
Sign up to save your podcasts
Or


BELIEVING IN HOPE WITHOUT COMPROMISE. Dr Virgilio Sacchini is dedicated to caring for people with breast cancer at the Memorial Sloan Kettering Cancer Center in New York. He originally trained at Universita degli Studi di Milano (UNIMI, Milan, Italy) where he is Professor of Surgery, and cooperates with the European Institute of Oncology in Milan (IEO, Milan, Italy). Dr Sacchini is a 2023 and 2024 Castle Connolly America's Top Doctor, the peer nominated group of the top 7% of all US practicing physicians. His goal is to achieve the best possible cancer outcomes and cosmetic results for his patients.
"The new concept is to target only cancer cells."
"To cure someone and give him or her a miserable life is terrible, so the target in this moment is both better survival and better quality of life, less side effects."
"Once we prove that the combination of the medication with the Avacta technique works, of course it is approved and you can be cured everywhere in the world."
By Alain Elkann4.3
66 ratings
BELIEVING IN HOPE WITHOUT COMPROMISE. Dr Virgilio Sacchini is dedicated to caring for people with breast cancer at the Memorial Sloan Kettering Cancer Center in New York. He originally trained at Universita degli Studi di Milano (UNIMI, Milan, Italy) where he is Professor of Surgery, and cooperates with the European Institute of Oncology in Milan (IEO, Milan, Italy). Dr Sacchini is a 2023 and 2024 Castle Connolly America's Top Doctor, the peer nominated group of the top 7% of all US practicing physicians. His goal is to achieve the best possible cancer outcomes and cosmetic results for his patients.
"The new concept is to target only cancer cells."
"To cure someone and give him or her a miserable life is terrible, so the target in this moment is both better survival and better quality of life, less side effects."
"Once we prove that the combination of the medication with the Avacta technique works, of course it is approved and you can be cured everywhere in the world."

6,821 Listeners

579 Listeners

151 Listeners

5,540 Listeners

2,448 Listeners

1,181 Listeners

216 Listeners

446 Listeners

490 Listeners

359 Listeners

141 Listeners

15,834 Listeners

299 Listeners

113 Listeners

22 Listeners